wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38941996-41C2F86B-98D3-4B1C-B4DA-411AC441B619
Q38941996-41C2F86B-98D3-4B1C-B4DA-411AC441B619
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38941996-41C2F86B-98D3-4B1C-B4DA-411AC441B619
Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.
P2860
Q38941996-41C2F86B-98D3-4B1C-B4DA-411AC441B619
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38941996-41C2F86B-98D3-4B1C-B4DA-411AC441B619
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ecf0a5d66ecfa99aefed1fea8318c101e90b869e
P2860
Imatinib tackles lymphoma via the PDGFRβ+ pericyte.